CN Patent

CN102197049B — 胰岛淀粉样多肽衍生物

Assigned to Novo Nordisk AS · Expires 2015-03-25 · 11y expired

What this patent protects

本发明涉及新型胰岛淀粉样多肽衍生物、包含所述衍生物的药物组合物以及使用本发明胰岛淀粉样多肽衍生物治疗糖尿病和高血糖症的方法。

USPTO Abstract

本发明涉及新型胰岛淀粉样多肽衍生物、包含所述衍生物的药物组合物以及使用本发明胰岛淀粉样多肽衍生物治疗糖尿病和高血糖症的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN102197049B
Jurisdiction
CN
Classification
—
Expires
2015-03-25
Drug substance claim
No
Drug product claim
No
Assignee
Novo Nordisk AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.